1991, Founded in Shenzhen, China
1993, Developed China's first multi-parameter patient monitor
1995, ISO 9001 certified by TUV
1998, Developed China's first 3-part differential haematology analyser
2000, Received first CE Mark clearance; began exporting products overseas
2001, Developed China's first digital diagnostic ultrasound imaging system
2003, Developed China's first automatic chemistry analyser
2004, Received first FDA 510(k) clearance; first products exported to the US Market
2006, Developed China's first 5-part differential haematology analyser
2006, Developed China's first digital colour Doppler ultrasound imaging system
2006, Listed on New York Stock Exchange under the ticker symbol "MR"
2007, Received the "2006 Global Market Penetration Leadership" and the "2007 Patient Monitoring Global Excellence" awards from the global growth consulting company, Frost & Sullivan
2008, Acquired Datascope's patient monitoring business, becoming the third-largest player in the global patient monitoring device industry

2010, Received the "2010 European Patient Monitoring Excellence in Globalisation Award" from the global growth consulting company, Frost & Sullivan

2010, Received the " 2010 Frost & Sullivan Award for Excellence in Innovation "
2011, Acquired a controlling stake in Shenke, Hyssen, Greenlander IT and TDR Biotech
2011, Received the “ 2011 Frost & Sullivan Excellence in Growth Award”
2012, established Miami R&D center